S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 94.9 TWD -1.15% Market Closed
Market Cap: 11.3B TWD
Have any thoughts about
SCI Pharmtech Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
SCI Pharmtech Inc

Current Assets 2B
Cash & Short-Term Investments 911.5m
Receivables 368.8m
Other Current Assets 739.3m
Non-Current Assets 4.8B
Long-Term Investments 454.8m
PP&E 3.9B
Intangibles 41.9m
Other Non-Current Assets 373.4m
Current Liabilities 778.3m
Accounts Payable 51.9m
Short-Term Debt 129m
Other Current Liabilities 597.4m
Non-Current Liabilities 1B
Long-Term Debt 870.4m
Other Non-Current Liabilities 133.4m

Balance Sheet
SCI Pharmtech Inc

Rotate your device to view
Balance Sheet
Currency: TWD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
399
370
327
256
361
554
633
332
167
942
Cash
170
192
89
156
148
224
284
304
75
908
Cash Equivalents
229
178
238
100
213
330
349
28
92
34
Short-Term Investments
169
432
538
415
430
466
0
360
98
89
Total Receivables
246
171
255
174
391
352
338
349
205
308
Accounts Receivables
237
168
249
174
389
352
338
83
174
307
Other Receivables
9
3
6
0
2
0
0
266
31
0
Inventory
510
554
498
483
503
527
381
294
513
530
Other Current Assets
0
9
5
12
22
37
567
62
60
85
Total Current Assets
1 330
1 536
1 623
1 339
1 707
1 936
1 919
1 397
1 042
1 953
PP&E Net
1 776
1 785
1 762
1 786
1 884
1 880
1 503
2 100
3 194
3 912
PP&E Gross
1 776
1 785
1 762
1 786
1 884
1 880
1 503
2 100
3 194
3 912
Accumulated Depreciation
1 157
1 263
1 350
1 416
1 522
1 584
695
638
707
839
Intangible Assets
0
0
0
1
47
48
41
60
55
46
Long-Term Investments
50
42
42
42
75
137
754
125
436
470
Other Long-Term Assets
65
93
123
127
75
80
353
507
233
310
Total Assets
3 221
N/A
3 457
+7%
3 550
+3%
3 296
-7%
3 789
+15%
4 081
+8%
4 570
+12%
4 190
-8%
4 961
+18%
6 691
+35%
Liabilities
Accounts Payable
80
67
58
35
89
94
81
34
49
44
Accrued Liabilities
92
108
117
75
132
153
119
78
85
82
Short-Term Debt
50
0
0
0
0
0
0
0
112
175
Current Portion of Long-Term Debt
0
0
0
0
0
2
1
2
1
22
Other Current Liabilities
175
498
280
233
336
335
921
635
524
247
Total Current Liabilities
397
673
455
343
557
584
1 122
748
770
570
Long-Term Debt
577
0
0
0
0
1
1
1
433
846
Deferred Income Tax
1
0
1
1
0
0
104
104
104
146
Other Liabilities
21
22
23
22
22
21
20
17
25
29
Total Liabilities
995
N/A
695
-30%
479
-31%
366
-24%
579
+58%
607
+5%
1 248
+106%
869
-30%
1 331
+53%
1 591
+19%
Equity
Common Stock
697
762
795
795
795
795
795
954
954
1 195
Retained Earnings
682
825
937
794
1 072
1 309
1 208
1 067
1 373
1 646
Additional Paid In Capital
858
1 186
1 348
1 348
1 348
1 348
1 348
1 348
1 357
2 234
Unrealized Security Profit/Loss
0
8
8
8
5
22
29
49
55
25
Other Equity
0
4
1
0
0
0
0
0
0
0
Total Equity
2 226
N/A
2 762
+24%
3 071
+11%
2 930
-5%
3 210
+10%
3 475
+8%
3 322
-4%
3 321
0%
3 629
+9%
5 100
+41%
Total Liabilities & Equity
3 221
N/A
3 457
+7%
3 550
+3%
3 296
-7%
3 789
+15%
4 081
+8%
4 570
+12%
4 190
-8%
4 961
+18%
6 691
+35%
Shares Outstanding
Common Shares Outstanding
70
76
95
95
95
95
109
109
109
120

See Also

Discover More